The IPO List
HomeListingsBlogsAboutJoin WhatsApp CommunityWhatsApp(Opens in a new tab)

The IPO List

Your trusted platform for IPO tracking and investment insights.

Quick Links

IPOsBlogsAboutContact

Legal

Privacy PolicyTerms of ServiceDisclaimer

© 2025 The IPO List. All rights reserved.

  1. Home/
  2. IPO Calendar/
  3. Aptus Pharma IPO
Aptus Pharma logo

Aptus Pharma

Upcoming
Upcoming

IPO Timeline

Issue open date

23 Sep 2025

Issue close date

25 Sep 2025

UPI mandate deadline

25 Sep 2025

Allotment finalization

26 Sep 2025

Refund initiation

29 Sep 2025

Share credit

29 Sep 2025

Listing date

30 Sep 2025

Mandate end date

10 Oct 2025

Lock-in end date for anchor investors (50%)

26 Oct 2025

Lock-in end date for anchor investors (remaining)

25 Dec 2025

Grey Market Premium Trend

₹7
Current GMP
₹77
Est. Listing Price
10.0%
Est. Listing Gain
₹65 - ₹70
Price Band

GMP History

DateGMP (₹)Est. Listing Price (₹)Est. Listing Gain
20 Sep₹7₹7710.00%
19 Sep₹7₹7710.00%
18 Sep₹7₹7710.00%
17 Sep₹0₹700.00%
16 Sep₹0₹700.00%
15 Sep₹0₹700.00%

Key Dates

Open
23 Sep 2025
Close
25 Sep 2025
Listing
30 Sep 2025

Quick Stats

Issue Size:13cr
Lot Size:2000 shares

Issue Details

Issue Size:13cr
Face Value:₹10
Listing At:BSE SME

Additional Resources

RHPRead(Opens in a new tab)
DRHPRead(Opens in a new tab)

About the Company

Aptus Pharma is a Gujarat-based pharmaceutical company incorporated in 2010, engaged in marketing and distribution of finished pharmaceutical formulations. The company operates through a contract manufacturing model without owning manufacturing facilities, partnering with seven manufacturing units. Aptus offers a diverse range of pharmaceutical products across therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, and wellness products. Products are available in various dosage forms including tablets, capsules, syrups, injections, ointments, and drops.

Strengths

  • Established presence in pharmaceutical marketing and distribution since 2010
  • Diverse product portfolio across multiple therapeutic categories and dosage forms
  • Partnership network with seven manufacturing units providing operational flexibility
  • Experienced promoter group with pharmaceutical industry expertise

Risks

  • Complete dependence on contract manufacturers creating supply chain vulnerabilities
  • Lack of manufacturing facilities limiting control over production quality and costs
  • Regulatory compliance risks across multiple therapeutic categories and formulations
  • Dependence on key manufacturing partners for business continuity and product quality

Aptus Pharma IPO – Frequently Asked Questions

  • The price band for the Aptus Pharma IPO is set at ₹65 to ₹70 per share.
  • The Aptus Pharma IPO opens on September 23, 2025 and closes on September 25, 2025.
  • The tentative listing date for the Aptus Pharma IPO is September 30, 2025.
  • You can apply for the Aptus Pharma IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Aptus Pharma, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Aptus Pharma IPO is 2000 shares. Investors must apply for at least one lot (i.e., 2000 shares).